AU2001240909A1 - Proteins, genes and their use for diagnosis and treatment of breast cancer - Google Patents

Proteins, genes and their use for diagnosis and treatment of breast cancer

Info

Publication number
AU2001240909A1
AU2001240909A1 AU2001240909A AU4090901A AU2001240909A1 AU 2001240909 A1 AU2001240909 A1 AU 2001240909A1 AU 2001240909 A AU2001240909 A AU 2001240909A AU 4090901 A AU4090901 A AU 4090901A AU 2001240909 A1 AU2001240909 A1 AU 2001240909A1
Authority
AU
Australia
Prior art keywords
genes
diagnosis
proteins
treatment
breast cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001240909A
Inventor
Herath Mudiyanselage Athula Chandrasiri Herath
Michael John O'hare
Martin John Page
Rajesh Bhikhu Parekh
Michael Derek Waterfield
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0006695A external-priority patent/GB0006695D0/en
Priority claimed from GB0007265A external-priority patent/GB0007265D0/en
Application filed by Oxford Glycosciences UK Ltd filed Critical Oxford Glycosciences UK Ltd
Publication of AU2001240909A1 publication Critical patent/AU2001240909A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
    • G06F16/50—Information retrieval; Database structures therefor; File system structures therefor of still image data
    • G06F16/54—Browsing; Visualisation therefor
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
    • G06F16/50—Information retrieval; Database structures therefor; File system structures therefor of still image data
    • G06F16/58—Retrieval characterised by using metadata, e.g. metadata not derived from the content or metadata generated manually
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
AU2001240909A 2000-03-20 2001-03-20 Proteins, genes and their use for diagnosis and treatment of breast cancer Abandoned AU2001240909A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0006695 2000-03-20
GB0006695A GB0006695D0 (en) 2000-03-20 2000-03-20 Breast cancer markers
GB0007265A GB0007265D0 (en) 2000-03-24 2000-03-24 Proteins and their uses for diagnosis and treatment of breast cancer
GB0007265 2000-03-24
PCT/GB2001/001219 WO2001071357A2 (en) 2000-03-20 2001-03-20 Diagnosis and treatment of breast cancer

Publications (1)

Publication Number Publication Date
AU2001240909A1 true AU2001240909A1 (en) 2001-10-03

Family

ID=26243912

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001240909A Abandoned AU2001240909A1 (en) 2000-03-20 2001-03-20 Proteins, genes and their use for diagnosis and treatment of breast cancer

Country Status (4)

Country Link
US (1) US20030064419A1 (en)
EP (1) EP1266225A2 (en)
AU (1) AU2001240909A1 (en)
WO (1) WO2001071357A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7054758B2 (en) * 2001-01-30 2006-05-30 Sciona Limited Computer-assisted means for assessing lifestyle risk factors
JP2005512517A (en) * 2001-09-27 2005-05-12 イ・デ・エム・イミュノ−デジネ・モレキュル Inducible Hsp70-derived polypeptide and pharmaceutical composition containing this polypeptide
US20040018973A1 (en) 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
DK1535076T3 (en) * 2002-08-23 2008-11-24 Bayer Healthcare Ag Polypeptide biomarkers for the diagnosis of Alzheimer's disease
WO2005040809A1 (en) * 2003-10-15 2005-05-06 Roche Diagnostics Gmbh Use of protein hnrnp-f as a marker for breast cancer
WO2005124357A1 (en) * 2004-06-18 2005-12-29 Roche Diagnostics Gmbh Use of protein elongation factor-1-alpha-1 as a marker for breast cancer
US20070264637A1 (en) * 2006-05-12 2007-11-15 Proyecto De Biomedicina Cima, S.L. 11q DELETION AS A MOLECULAR GENETIC MARKER IN BREAST CANCER
FR2919060B1 (en) * 2007-07-19 2012-11-30 Biomerieux Sa METHOD OF DETERMINING EZRINE FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
CA2693098C (en) 2007-07-19 2019-06-18 Yasemin Ataman-Onal Dosage method for the carcino-embryonic antigen and the carbohydrate 19-9 antigen to hepatic fatty acid-binding protein for the diagnosis of colorectal cancer
FR2919065B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD FOR DETERMINING APOLIPOPROTEIN AI FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
FR2919063B1 (en) 2007-07-19 2009-10-02 Biomerieux Sa METHOD OF DETERMINING LEUCOCYTE ELASTASE INHIBITOR FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER.
FR2933773B1 (en) 2008-07-10 2013-02-15 Biomerieux Sa METHOD FOR DETERMINING THE ISOMERASE DISULFIDE PROTEIN FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER
DE102008045511A1 (en) * 2008-09-03 2010-03-04 Henkel Ag & Co. Kgaa Hair treatment preparations with low-dose oligopeptides
WO2012148720A2 (en) * 2011-04-27 2012-11-01 The Regents Of The University Of California Anti-microbial peptides and methods of use thereof
CN103854276B (en) * 2012-12-04 2018-02-09 东芝医疗系统株式会社 Image registration and segmenting device and method, and medical image equipment
US10613090B2 (en) 2014-05-09 2020-04-07 Ascendant Diagnostics, LLC Methods of detecting cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0345726A3 (en) * 1988-06-07 1991-07-03 Institute For Medical Research Plastin isoforms and their uses
US5914238A (en) * 1996-06-05 1999-06-22 Matritech, Inc. Materials and methods for detection of breast cancer
US6500937B1 (en) * 1996-10-03 2002-12-31 University Of Michigan Nucleotide sequence encoding a mammary cell growth inhibitor
WO1998022139A1 (en) * 1996-11-22 1998-05-28 La Jolla Institute For Allergy And Immunology Detection of galectin-4 in human tumors
AUPO500997A0 (en) * 1997-02-07 1997-03-06 Macquarie Research Limited Diagnosis of disease using tears
US5994081A (en) * 1998-04-27 1999-11-30 Incyte Pharamaceuticals, Inc. Human keratins
AU3246200A (en) * 1999-02-25 2000-09-14 Boris Bilynsky Nucleic acid molecules associated with melanoma and thyroid tumors
GB9905817D0 (en) * 1999-03-12 1999-05-05 Oxford Glycosciences Uk Ltd Methods

Also Published As

Publication number Publication date
US20030064419A1 (en) 2003-04-03
WO2001071357A2 (en) 2001-09-27
EP1266225A2 (en) 2002-12-18
WO2001071357A3 (en) 2002-05-16

Similar Documents

Publication Publication Date Title
AU2002251366A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
AU2002216273A1 (en) Proteins, genes and their use for diagnosis and treatment of kidney response
HUP0200763A2 (en) Compositions for the treatment and diagnosis of breast cancer and methods for their use
AU2001240909A1 (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
AU3391200A (en) Compositions and methods for breast cancer therapy and diagnosis
AU6583700A (en) Proteins, genes and their use for diagnosis and treatment of breast cancer
AU2001252945A1 (en) Compositions and methods for therapy and diagnosis of colon cancer
AU5947701A (en) Methods for identification, diagnosis, and treatment of breast cancer
AU2001243349A1 (en) Methods for the diagnosis and treatment of breast cancer
AU6425800A (en) Agents for the diagnosis, prognosis and treatment of malignant diseases
AU3177500A (en) Proteins for diagnosis and treatment of breast cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
PL366066A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001233954A1 (en) Proteins, genes and their use for diagnosis and treatment of schizophrenia
ZA200108256B (en) Compositions and methods for the treatment and diagnosis of breast cancer.
AU2001271365A1 (en) Cyr61 as a target for treatment and diagnosis of breast cancer
AU2002253899A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2002251367A1 (en) Proteins and genes for diagnosis and treatment of erbb2-related cancer
AU2001240820A1 (en) Proteins, genes and their use for diagnosis and treatment of vascular dementia
AU2002346049A1 (en) Coactivators in the diagnosis and treatment of breast cancer
AU5618700A (en) Extracellular camp-dependent protein kinase in diagnosis, prognosis and treatment of cancer
AU2001280443A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2002365104A1 (en) Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof
GB0120926D0 (en) Proteins,genes and their use for diagnosis and treatment of breast cancer